Syngene International Limited has informed the Exchange regarding a press release dated April 29, 2026, titled "Full-year revenue from operations up 3% to Rs. 3,739 Cr; Fourth quarter revenue from operations up 2% year-on-year to Rs. 1,037 Cr.".
Press Release Apr 29 2026
Filed with NSE ·
6ix hasn’t read this filing yet.
Syngene International Ltd. on 6ix
In the deck
Earlier from Syngene International
- Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
- VivaMed BioPharma Partners With Syngene International to Advance AI-Derived Repurposed Therapeutic Programs Through Global Validation Infrastructure
- Press Release Jan 22 2026
- Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
- Press Release Jan 19 2026
Later from Syngene International
- Syngene strengthens leadership team with two key appointments
- Syngene International Ltd. Press Release Jul 01 2026
- Syngene International Ltd. Press Release Jul 29 2026
- Syngene International Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Syngene reports sequential revenue growth of 13% in Q2 FY27; Operating EBITDA margin improves by 6 percentage points".
Follow Syngene International into a list and get an email when it puts out news.
Follow Syngene International